Technical Analysis for BIB - ProShares Ultra Nasdaq Biotechnology

Grade Last Price % Change Price Change
grade F 43.75 -4.58% -2.10
BIB closed down 4.58 percent on Tuesday, December 18, 2018, on 1.59 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
6 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BIB trend table...

Date Alert Name Type % Chg
Dec 18 New 52 Week Closing Low Bearish 0.00%
Dec 18 Lower Bollinger Band Walk Weakness 0.00%
Dec 18 New 52 Week Low Weakness 0.00%
Dec 18 Below Lower BB Weakness 0.00%
Dec 18 Down 3 Days in a Row Weakness 0.00%
Dec 18 Down 4 Days in a Row Weakness 0.00%
Dec 18 Lower Bollinger Band Touch Weakness 0.00%
Dec 18 Oversold Stochastic Weakness 0.00%
Dec 17 New 52 Week Closing Low Bearish -4.58%
Dec 17 New 52 Week Low Weakness -4.58%

Older signals for BIB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:

Profile
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Is BIB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 13 Senate Dems introduce bill to block "excessive" increases in drug prices
Dec 11 Trump Foreshadows a Bleak Outlook for Biotech (IBB, BIB)
Dec 3 Trump cabinet members submit plan on reforming U.S. healthcare
Nov 28 ROBO Vs. BIB: Picking The Better ETF Opportunity
Nov 28 Biotechs could face cash crunch next year - Leerink
Nov 1 Money flow returns to biotechs, XBI up 4%
Oct 31 Biotech IPOs on pace for near-record year - WSJ
Oct 30 FDA announces action plan to advance innovation in plant and animal biotech
Oct 29 Stocks Still Looking for the Bottom
Oct 26 Trump mulling tieing U.S. drug prices to Europe's
See more BIB news...
Indicators
Indicator Value
52 Week High 70.82
52 Week Low 42.95
Average Volume 206,094
200-Day Moving Average 58.1828
50-Day Moving Average 52.6334
20-Day Moving Average 50.05
10-Day Moving Average 48.965
Average True Range 2.8554
ADX 23.5
+DI 15.9856
-DI 37.1809
Chandelier Exit (Long, 3 ATRs ) 48.4338
Chandelier Exit (Short, 3 ATRs ) 51.5162
Upper Bollinger Band 55.6061
Lower Bollinger Band 44.4939
Percent B (%b) -0.07
BandWidth 22.202198
MACD Line -1.7628
MACD Signal Line -1.2264
MACD Histogram -0.5364
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 49.14
Resistance 3 (R3) 49.47 48.00 48.24
Resistance 2 (R2) 48.00 46.63 47.84 47.94
Resistance 1 (R1) 45.88 45.78 45.15 45.55 47.64
Pivot Point 44.41 44.41 44.05 44.25 44.41
Support 1 (S1) 42.29 43.04 41.56 41.96 39.86
Support 2 (S2) 40.82 42.19 40.66 39.56
Support 3 (S3) 38.70 40.82 39.26
Support 4 (S4) 38.37